IL-17 receptor adaptor protein Act1/CIKS plays an evolutionarily conserved role in antiviral signaling

Journal of Immunology

Volumn 189, Issue 10, 2012, Pages 4852-4858

  Ryzhakov, Grigory ^a   Blazek, Katrina ^a   Lai, Cheryl Chuk Ke ^b   Udalova, Irina A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BETA INTERFERON; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 17 RECEPTOR; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN ACT1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS GENE;

ANIMALS; CELL LINE, TUMOR; EVOLUTION, MOLECULAR; FIBROBLASTS; HUMANS; I-KAPPA B KINASE; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MUTATION; RNA VIRUS INFECTIONS; RNA VIRUSES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84868527292     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200428     Document Type: Article

References (48)

1. Kawai, T., and S. Akira. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141: 137-145.
2. Meylan, E., and J. Tschopp. 2006. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell 22: 561-569.
3. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17: 1-14.
4. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
5. Takeuchi, O., and S. Akira. 2008. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20: 17-22.
6. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Tolllike receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6: 644-658.
7. Collins, S. E., R. S. Noyce, and K. L. Mossman. 2004. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J. Virol. 78: 1706-1717.
8. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
9. Opitz, B., M. Vinzing, V. van Laak, B. Schmeck, G. Heine, S. Günther, R. Preissner, H. Slevogt, P. D. N'Guessan, J. Eitel, et al. 2006. Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J. Biol. Chem. 281: 36173-36179.
10. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17: 1087-1095.
11. Lin, R., Y. Mamane, and J. Hiscott. 1999. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and auto-inhibitory domains. Mol. Cell. Biol. 19: 2465-2474.
12. Lin, R., C. Heylbroeck, P. M. Pitha, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear transloca-tion, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18: 2986-2996.
13. Mori, M., M. Yoneyama, T. Ito, K. Takahashi, F. Inagaki, and T. Fujita. 2004. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J. Biol. Chem. 279: 9698-9702.
14. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496.
15. Servant, M. J., B. ten Oever, C. LePage, L. Conti, S. Gessani, I. Julkunen, R. Lin, and J. Hiscott. 2001. Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J. Biol. Chem. 276: 355-363.
16. Matsui, K., Y. Kumagai, H. Kato, S. Sato, T. Kawagoe, S. Uematsu, O. Takeuchi, and S. Akira. 2006. Cutting edge: Role of TANK-binding kinase 1 and inducible IkappaB kinase in IFN responses against viruses in innate immune cells. J. Immunol. 177: 5785-5789.
17. Tenoever, B. R., S. L. Ng, M. A. Chua, S. M. McWhirter, A. Garćia-Sastre, and T. Maniatis. 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315: 1274-1278.
18. Kawai, T., and S. Akira. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 1143: 1-20.
19. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643.
20. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
21. Oganesyan, G., S. K. Saha, B. Guo, J. Q. He, A. Shahangian, B. Zarnegar, A. Perry, and G. Cheng. 2006. Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response. Nature 439: 208-211.
22. Novatchkova, M., A. Leibbrandt, J. Werzowa, A. Neubüser, and F. Eisenhaber. 2003. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28: 226-229.
23. Qian, Y., C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256.
24. Qian, Y., J. Qin, G. Cui, M. Naramura, E. C. Snow, C. F. Ware, R. L. Fairchild, S. A. Omori, R. C. Rickert, M. Scott, et al. 2004. Act1, a negative regulator in CD40-and BAFF-mediated B cell survival. Immunity 21: 575-587.
25. Swaidani, S., K. Bulek, Z. Kang, C. Liu, Y. Lu, W. Yin, M. Aronica, and X. Li. 2009. The critical role of epithelial-derived Act1 in IL-17-and IL-25-mediated pulmonary inflammation. J. Immunol. 182: 1631-1640.
26. Pisitkun, P., E. Claudio, N. Ren, H. Wang, and U. Siebenlist. 2010. The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody. Arthritis Rheum. 62: 3334-3344.
27. Qian, Y., N. Giltiay, J. Xiao, Y. Wang, J. Tian, S. Han, M. Scott, R. Carter, T. N. Jorgensen, and X. Li. 2008. Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome. Eur. J. Immunol. 38: 2219-2228.
28. Li, X. 2008. Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine 41: 105-113.
29. Chang, S. H., H. Park, and C. Dong. 2006. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281: 35603-35607.
30. Valente, A. J., R. A. Clark, J. M. Siddesha, U. Siebenlist, and B. Chandrasekar. 2012. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy. J. Mol. Cell Cardiol. 53: 113-124.
31. Liu, C., W. Qian, Y. Qian, N. V. Giltiay, Y. Lu, S. Swaidani, S. Misra, L. Deng, Z. J. Chen, and X. Li. 2009. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci. Signal. 2: ra63.
32. Li, X., M. Commane, H. Nie, X. Hua, M. Chatterjee-Kishore, D. Wald, M. Haag, and G. R. Stark. 2000. Act1, an NF-kappa B-activating protein. Proc. Natl. Acad. Sci. USA 97: 10489-10493.
33. Kanamori, M., C. Kai, Y. Hayashizaki, and H. Suzuki. 2002. NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6. FEBS Lett. 532: 241-246.
34. Ryzhakov, G., K. Blazek, and I. A. Udalova. 2011. Evolution of vertebrate immunity: sequence and functional analysis of the SEFIR domain family member Act1. J. Mol. Evol. 72: 521-530.
35. Qian, Y., Z. Zhao, Z. Jiang, and X. Li. 2002. Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells. Proc. Natl. Acad. Sci. USA 99: 9386-9391.
36. Leonardi, A., A. Chariot, E. Claudio, K. Cunningham, and U. Siebenlist. 2000. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc. Natl. Acad. Sci. USA 97: 10494-10499.
37. Bulek, K., C. Liu, S. Swaidani, L. Wang, R. C. Page, M. F. Gulen, T. Herjan, A. Abbadi, W. Qian, D. Sun, et al. 2011. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat. Immunol. 12: 844-852.
38. Zhao, T., L. Yang, Q. Sun, M. Arguello, D. W. Ballard, J. Hiscott, and R. Lin. 2007. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat. Immunol. 8: 592-600.
39. Hartupee, J., C. Liu, M. Novotny, D. Sun, X. Li, and T. A. Hamilton. 2009. IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6. J. Immunol. 182: 1660-1666.
40. Ryzhakov, G., C. C. Lai, K. Blazek, K. W. To, T. Hussell, and I. Udalova. 2011. IL-17 boosts proinflammatory outcome of antiviral response in human cells. J. Immunol. 187: 5357-5362.
41. Hardy, M. P., A. F. McGGettrick, and L. A. O'Neill. 2004. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene. Biochem. J. 380: 83-93.
42. Zhao, Z., Y. Qian, D. Wald, Y. F. Xia, J. G. Geng, and X. Li. 2003. IFN regulatory factor-1 is required for the up-regulation of the CD40-NF-kappa B activator 1 axis during airway inflammation. J. Immunol. 170: 5674-5680.
43. Ryzhakov, G., and F. Randow. 2007. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J. 26: 3180-3190.
44. Mauro, C., P. Vito, S. Mellone, F. Pacifico, A. Chariot, S. Formisano, and A. Leonardi. 2003. Role of the adaptor protein CIKS in the activation of the IKK complex. Biochem. Biophys. Res. Commun. 309: 84-90.
45. Wu, B., M. Jin, J. Gong, X. Du, and Z. Bai. 2011. Dynamic evolution of CIKS (TRAF3IP2/Act1) in metazoans. Dev. Comp. Immunol. 35: 1186-1192.
46. Workenhe, S. T., M. L. Rise, M. J. Kibenge, and F. S. Kibenge. 2010. The fight between the teleost fish immune response and aquatic viruses. Mol. Immunol. 47: 2525-2536.
47. Zhu, S., W. Pan, P. Shi, H. Gao, F. Zhao, X. Song, Y. Liu, L. Zhao, X. Li, Y. Shi, and Y. Qian. 2010. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling. J. Exp. Med. 207: 2647-2662.
48. Chariot, A., A. Leonardi, J. Muller, M. Bonif, K. Brown, and U. Siebenlist. 2002. Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J. Biol. Chem. 277: 37029-37036.